Peters, M. http://orcid.org/0000-0002-4268-0548
van den Bergh, J. P.
Geusens, P.
Scharmga, A.
Loeffen, D.
Weijers, R.
van Rietbergen, B.
van Tubergen, A.
Funding for this research was provided by:
Pfizer (WS2056904)
Stichting De Weijerhorst (WH-2)
Article History
Received: 11 November 2018
Accepted: 30 December 2018
First Online: 1 February 2019
Compliance with Ethical Standards
:
: P. Geusens: grants received from AMGEN, ABBVIE, MSD, WILL, ROCHE, BMS, and UCB. B. van Rietbergen: consultant for Scanco Medical AG. The other authors have no conflict of interest.
: All subjects signed informed consent. Ethical approval was obtained from the ethics board of the academic hospital Maastricht/Maastricht University, the Netherlands. Netherlands Trial Registry number: NTR3821.